|Development of dermatomyofibroma in a male infant.|
|Jump to Full Text|
|PMID: 22028578 Owner: NLM Status: PubMed-not-MEDLINE|
|Dermatomyofibroma is a rare benign cutaneous mesenchymal neoplasm of the fibroblasts and myofibroblasts. The majority of dermatomyofibromas present as red-brown discolored plaques or nodules, commonly located on the shoulder, upper arm, axilla, neck, and/or upper trunk. These lesions develop most frequently in young female patients at a mean of 28-years-of-age. Herein, a case of dermatomyofibroma is reported that developed in an infant. A 4-month-old boy presented with an ill-defined bluish firm plaque on the trunk that developed 1 month after birth. Histopathologically, there was proliferation of bland-looking spindle cells with fascicular arrangement in the dermis and subcutaneous tissue. Immunohistochemistry showed that most of the tumor cells expressed diffuse positivity for vimentin and smooth muscle actin, but were negative for S-100 protein, desmin, and CD34.|
|Ji Hyun Sim; Jaeyoung Shin; Daniel P Vandersteen; You Chan Kim|
Related Documents :
|19889368 - Social cognition: evolutionary history of emotional engagements with infants.
2054928 - Early patterns of interaction between blind infants and their sighted mothers.
20438178 - Brain-behavior correlations: relationships between mother-stranger face processing and ...
16684198 - Guiding mothers' management of health problems of very low birth-weight infants.
22179128 - A possible murine model for investigation of pathogenesis of sudden infant death syndrome.
10232648 - Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology...
|Type: Journal Article Date: 2011-09-30|
|Title: Annals of dermatology Volume: 23 Suppl 1 ISSN: 2005-3894 ISO Abbreviation: Ann Dermatol Publication Date: 2011 Sep|
|Created Date: 2011-10-26 Completed Date: 2011-11-10 Revised Date: 2013-05-29|
Medline Journal Info:
|Nlm Unique ID: 8916577 Medline TA: Ann Dermatol Country: Korea (South)|
|Languages: eng Pagination: S72-4 Citation Subset: -|
|Department of Dermatology, Ajou University School of Medicine, Suwon, Korea.|
|APA/MLA Format Download EndNote Download BibTex|
Journal ID (nlm-ta): Ann Dermatol
Journal ID (publisher-id): AD
Publisher: Korean Dermatological Association; The Korean Society for Investigative Dermatology
Copyright © 2011 Korean Dermatological Association; The Korean Society for Investigative Dermatology
Received Day: 16 Month: 8 Year: 2010
Revision Received Day: 14 Month: 9 Year: 2010
Accepted Day: 20 Month: 9 Year: 2010
Print publication date: Month: 9 Year: 2011
Electronic publication date: Day: 30 Month: 9 Year: 2011
Volume: 23 Issue: Suppl 1
First Page: S72 Last Page: S74
PubMed Id: 22028578
|Development of Dermatomyofibroma in a Male Infant|
|Ji Hyun Sim, M.D.A1|
|Jaeyoung Shin, M.D.A1|
|Daniel P. Vandersteen, M.D.1|
|You Chan Kim, M.D.A1|
|Department of Dermatology, Ajou University School of Medicine, Suwon, Korea.
1Department of Pathology, St Mary's/Duluth Clinic Health System, Duluth, MN, USA.
Corresponding author: You Chan Kim, M.D., Department of Dermatology, Ajou University School of Medicine, 5 Wonchon-dong, Yeongtong-gu, Suwon 443-721, Korea. Tel: 82-31-219-5190, Fax: 82-31-219-5189, firstname.lastname@example.org
Dermatomyofibroma is a rare benign cutaneous mesenchymal neoplasm of fibroblasts and myofibroblasts that was first reported in 19921. The lesions are most common in adolescents and young adults. The mean age of diagnosis is 28 years and only a few cases have been reported in childhood2,3. Herein, we present a case of dermatomyofibroma in a male infant.
A 4-month-old boy presented with an asymptomatic lesion on the trunk. According to the parents, the lesion was first noticed 1 month after birth and had gradually increased in size as the child grew. The family and medical histories were noncontributory. The physical examination revealed an ill-defined bluish firm plaque 2~3 cm on the left flank (Fig. 1). Histopathological examination was performed and the specimen showed dermal proliferation of spindle-shaped tumor cells parallel to the epidermis, in the reticular dermis, extending focally into the subcutaneous tissue (Fig. 2). There was no cytological atypia or mitotic figures. Immunohistochemistry showed that most of the tumor cells expressed diffuse positive responses for vimentin and smooth muscle actin (Fig. 3), but were negative for S-100 protein, desmin, and CD34. The lesion remained stable without any significant changes during 5 months of clinical bservation.
The majority of dermatomyofibromas present as red-brown discolored plaques or nodules4. Dermatomyofibroma develops most frequently in young female patients, and commonly occurs on the shoulder, upper arm, axilla, neck, and/or the upper trunk. In a recent study, female and male children and adolescent atients were reported to be affected equally, in contrast to the female dominant pattern in adults2.
To date, only six cases have been reported under the age of 5 years, all of them being boys. Among those, three cases occurred in the infantile period1-6. It has been suggested that dermatomyofibroma in male children tends to show spontaneous regression after childhood, whereas the lesions continue to grow in female patients, possibly due to the effects of female hormones2,5. However, there is no proof for this hypothesis. Further studies evaluating the expression of hormone receptors in the tissue specimen will be of value to clarify this hypothesis.
Histologically, most cases of dermatomyofibroma have a benign, ill-defined, plaque-like dermal proliferation of spindle-shaped tumor cells often arranged parallel to the epidermis1,2. The tumor cells fill the reticular dermis and sometimes extend into the upper part of the subcutaneous layer, whereas the papillary dermis and adnexal structures are spared. The overlying epidermis appears normal, although sometimes a mild basal hyperpigmentation is observed5. The elastic fibers are preserved; this finding provides a clue to the diagnosis, because dermatofibroma and hypertrophic scars have altered elastic fibers5. Immunohistochemistry should be considered for cases that have non-specific histopathological features. The spindle cells stain positive for vimentin and are occasionally positive for smooth muscle actin. However, they are negative for S-100 protein, desmin, and CD347.
Clinically, scar or keloid should be distinguished from dermatomyofibroma. However, frequently there is a preceding history of trauma or surgery in a scar or keloid. In addition, a whorl-like or nodular structure with no or few adnexae is observed3. The histological differential diagnosis of dermatomyofibroma includes dermatofibromas, dermatofibrosarcoma protuberans, and fibrous hamartoma of infancy. Dermatofibromas are not as plaque-like and are more likely to show epidermal hyperplasia and a haphazard architecture as opposed to the fascicles of dermatomyofibromas, which are parallel to the epidermal surface8.
In addition, there is a reduction or loss of elastic fibers and involvement of adnexal structures4. Dermatofibrosarcoma protuberans shows a more intense cellular infiltration with storiform architecture and, unlike dermatomyofibroma, it is positive for CD344. In the present case, a fibro/myofibroblastic proliferation, as in fibrous hamartomas of infancy, should have been part of the differential diagnosis, since the patient was an infant. However, fibrous hamartomas of infancy could be excluded because they consist of three distinct components: the combination of fibrocollagenous trabeculae composed of bland spindle cells, small nests of loosely arranged oval or stellate mesenchymal cells set in a myxoid stroma, and mature fat2.
The prognosis of dermatomyofibroma is favorable and surgical excision is the treatment of choice. No recurrence or metastasis has been reported yet. In this case, the patient was observed closely without treatment, since dermatomyofibroma in males may regress spontaneously after childhood6.
In summary, dermatomyofibroma is a distinctive benign dermal myofibroblastic proliferation that is rare in children, especially during infancy. However, clinicians should consider the diagnosis when characteristic myofibroblastic proliferation is present on skin biopsy.
|1.||Gilaberte Y,Coscojuela C,Doste D,Vera J,Requena L. Dermatomyofibroma in a male childJ Eur Acad Dermatol VenereolYear: 20051925725915752309|
|2.||Mentzel T,Kutzner H. Dermatomyofibroma: clinicopathologic and immunohistochemical analysis of 56 cases and reappraisal of a rare and distinct cutaneous neoplasmAm J DermatopatholYear: 200931444919155724|
|3.||Kim SH,Oh JJ,Lee JH,Lee ES. A case of dermatomyofibroma in a 2 year old boyAnn DermatolYear: 2003156870|
|4.||Mortimore RJ,Whitehead KJ. Dermatomyofibroma: a report of two cases, one occurring in a childAustralas J DermatolYear: 200142222511233715|
|5.||Rose C,Bröcker EB. Dermatomyofibroma: case report and reviewPediatr DermatolYear: 19991645645910632944|
|6.||Kamino H,Reddy VB,Gero M,Greco MA. Dermatomyofibroma. A benign cutaneous, plaque-like proliferation of fibroblasts and myofibroblasts in young adultsJ Cutan PatholYear: 19921985931597573|
|7.||Viglizzo G,Occella C,Calonje E,Nozza P,Rongioletti F. A unique case of multiple dermatomyofibromasClin Exp DermatolYear: 20083362262418801097|
|8.||Prieto VG,Reed JA,Shea CR. Immunohistochemistry of dermatofibromas and benign fibrous histiocytomasJ Cutan PatholYear: 1995223363417499573|
Keywords: Dermatomyofibroma, Infant.
Previous Document: Treatment of verrucous carcinoma of the lower lip with topical imiquimod (aldara®) and debulking th...
Next Document: Treatment using a long pulsed nd:yag laser with a pulsed dye laser for four cases of blebbed port wi...